Back to search
FDAFDA · Food and drugs·Recall number Z-1714-2020

VACUETTE Tube 2ml 9NC Coagulation Sodium Citrate 3.2%. Item no. 454322. Lot no. B1908355.

Published April 22, 2020 · Recall initiated: March 12, 2020

Summary

FDA records medical device Class II recall Z-1714-2020, published April 22, 2020 and initiated March 12, 2020. Recalling firm: Greiner Bio-One North America, Inc.; Status: Terminated; Reported quantity: 1,000,800 units.; Lot: Item no. 454322. Lot no. B1908355. DI no. (01)29120017574488 (17) 200809 (10)B1908355. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Concerned lot of VACETTE 2mL 9NC Coagulation Tubes were shown to have inconsistent amounts of the 2.3% sodium citrate.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Greiner Bio-One North America, Inc.
Distributor
US nationwide distribution in the states of: NJ, IN, TN, MI, NC, WA, KS, CA, LA, IL, MD, NY, OH, TX, GA, KY, PA, CO, MA, PR, FL, AR, OK and NE.
Lot
Item no. 454322. Lot no. B1908355. DI no. (01)29120017574488 (17) 200809 (10)B1908355.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VACUETTE Tube 2ml 9NC Coagulation Sodium Citrate 3.2%. Item no. 454322. Lot no. B1908355. recalled?

Yes. FDA published recall Z-1714-2020 on April 22, 2020. Reported hazard: Concerned lot of VACETTE 2mL 9NC Coagulation Tubes were shown to have inconsistent amounts of the 2.3% sodium citrate.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail